Bladder Cancer Canada (BCC) is thrilled to congratulate Dr. Michael A.S. Jewett, Professor of Surgery (Urology) at the Princess Margaret Cancer Centre and at the University of Toronto, for his appointment to the Order of Canada,Read more

Wearing a mask in public spaces during COVID has been a challenge for so many of us. But for Cathy, who reads lips to communicate with others, it’s muted the world around her. Cathy, whoRead more

Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

Dearest Friend, Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that’s affecting us all on some level. For those of you diagnosed with bladder cancer, undergoing treatment,Read more

Dear Friend of Bladder Cancer Canada,Please help us understand what patients and caregivers think is important in bladder cancer research.Below is a link to a patient and caregiver survey that has been designed by our colleagues atRead more

(The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

Bladder Cancer Canada was recently reviewed by Charity Intelligence, an independent organization that researches Canadian charities so that donors can be well informed and give intelligently.  Of the 750 charities that Charity Intelligence has reviewed,Read more

IMPORTANT UPDATE – March 9, 2020 Bladder Cancer Canada (BCC) and its Medical Advisory Board were advised by Merck Canada in November 2019 that they would continue to face challenges in the supply of the TICERead more

TORONTO, CANADA (May 15, 2020) – This year, 12,000 Canadians will be diagnosed with bladder cancer, and for many of these Canadians, the global development of COVID-19 will impact bladder cancer diagnoses, treatments and outcomes.Read more

Posted July 30, 2020. Watch Webinar In this webinar, Dr. Girish Kulkarni set a foundation of the basics of clinical trials (what they are, how are they designed, terminology, etc.).  He then delved deeper into aspectsRead more

Many of us at Bladder Cancer Canada are saddened by the news of the recent passing of Paul Unterman, a volunteer and former board member, to bladder cancer. Paul volunteered on the board of directorsRead more

At a recent Board of Director’s meeting, and on behalf of the board and the Medical Advisory and Research Boards, BCC chair Ferg Devins was pleased to present the Founders’ Award to his friend andRead more

We met up with our Executive Director Dr. Dionne Duncan and her good friend Mel on the waterfront in beautiful Port Credit, Ontario. Dionne and Mel demonstrate how we can support each other this SeptemberRead more

Our February newsletter shows how awareness efforts help save lives. Read newsletter Newsletter Highlight: What to know about BCG treatments, COVID-19 and the vaccine We recently collaborated with members of our Medical Advisory Board toRead more

The Board of Directors of Bladder Cancer Canada wishes to advise of a recent change in the leadership at Bladder Cancer Canada. Effective August 7th, 2020, Dr. Dionne Duncan is no longer in the employRead more

It is hard to believe, but it is once again time for our Bladder Cancer Awareness Walk, and due to the precautions that we are taking because of COVID -19, the walk will be virtual this year. Over the pastRead more